Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2008-09-30
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary research hypothesis: Women undergoing speculum examination will experience at least 20% less physical discomfort, 20% less sense of vulnerability, and 20% less sense of loss of control when using a no-stirrup method of examination compared to traditional in-stirrup examinations.
Secondary research hypothesis: 25% or less of the providers taught this alternative method of speculum examination will find it to be unacceptable.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Comparison of Vaginal Self Sampling for Human Papillomavirus (HPV) Testing by Standard Versus Dry Vaginal Swabs
NCT01316120
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
NCT05557318
Pap Smear Research Study
NCT00743626
Does Elective Amniocentesis Change Vaginal Microbiome?
NCT03884361
Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia
NCT00520455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will undergo speculum examination with medium Graves speculum. Patients needing, or requesting, other size speculums will be removed from the study. The participating provider will fill out the top of the data collection sheets and the patient will be asked to fill out the bottom of the sheet after the provider leaves the room. The sheets will then be dropped off at the nurses' station or leave them in the examination room.
Multiple aspects of physical discomfort, sense of control and sense of vulnerability will be assessed using a continuous scale. Patients will be asked to place a mark on a continuous line between two extremes. The distance will then be measured in millimeters in order to convert it to a numeric value. The measurement will be done by an independent provider in a blinded manner.
Medical providers participating in the study will be consented for enrollment. They will be mailed consent forms and asked to sign them in front of a witness and mail the consent form back to the PI. They will be eligible as long as they believe they can enroll 25 patients over the course of approximately one year. Providers will be trained on how to perform a no-stirrup examination. The training will include standardized draping of patients as well as standardized positioning of patients in order to reduce the amount of variation introduced by the providers into these examinations. The training will include still images and an instructional video. The Principal Investigator will be available to anyone who has further questions regarding the technique. Participating providers will also be asked to perform at least 5 no-stirrup examinations on non-study subjects prior to beginning enrollment into the study to ensure familiarization with the technique. Providers will be recruited if they agree to attempt to enroll 25 or more patients to the study over the course of approximately one year. This will not be a difficult number to achieve for an active clinician.
Providers who had not been trained on the no-stirrup speculum examination prior to the beginning this study will be sent a questionnaire querying them about their experience with the method after all data is collected.
Protected Health Information will not be collect, so HIPAA forms will not be required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Stirrups
Vaginal speculum examinations done without stirrups. The woman's feet will be placed onto the exam table allowing maximal repositioning by the woman.
no-stirrup vaginal examination
Vaginal speculum examination done with feet on table extender.
Stirrups
Speculum examination with feet in stirrups. The woman's feet will be placed into obstetric stirrups which fix the feet in place.
Vaginal speculum examination done with stirrups.
Speculum examination done with feet in stirrups.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no-stirrup vaginal examination
Vaginal speculum examination done with feet on table extender.
Vaginal speculum examination done with stirrups.
Speculum examination done with feet in stirrups.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pap smears during well woman examinations
* Pap smears during routine early pregnancy visit
* vaginal discharge
* vaginal bleeding
* sexually transmitted disease check
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pearl Network
NETWORK
Eisenhower Army Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dean A Seehusen, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Eisenhower Army Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eisenhower Army Medical Center
Fort Gordon, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DDEAMC 07-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.